LucyRx’s approach reduces treatment delays and promotes coordinated pharmacy care for patients with complex conditions. Patients seeing their physician and receiving other care may access on-site specialty pharmacies, a benefit shown to improve adherence, symptom management and overall patient outcomes. The nation’s most esteemed health centers, including Northwestern Medicine Specialty Pharmacy, Boston Children’s Hospital, Dana Farber Cancer Institute, Penn Medicine, and City of Hope, are included in the network.
“Some patients don’t have time to wait,” said David Blair, CEO of LucyRx. “Every day matters when starting treatment, and delays impact survival rates and quality of life. Our vast pharmacy network is designed to ensure that no patient faces unnecessary hurdles in getting the care they need.”
Specialty pharmacies provide therapeutic medications for patients with a variety of illnesses, including:
Cancer: Including breast cancer, lung cancer, and hematologic malignancies.
Autoimmune Diseases: Conditions such as rheumatoid arthritis, multiple sclerosis, and Crohn’s disease.
Rare Diseases: The network supports treatments for rare and orphan diseases.
Chronic Conditions: Diseases like diabetes, cardiovascular diseases, and chronic respiratory conditions.
LucyRx’s expanded pharmacy network highlights the company’s commitment to providing comprehensive and integrated care for patients with even the most complex health needs.
Studies show that cancer patients receiving medications through integrated specialty pharmacies experience fewer emergency room visits, lower rates of treatment disruption and better symptom control, leading to improved health outcomes and quality of life. By ensuring timely access to essential medications, LucyRx is removing unnecessary barriers that delay care.
Share